Mon, Dec 22, 2014
A A A
Welcome Guest
Free Trial RSS
Get FREE trial access to our award winning publications
Opalesque Radio

Wine as an asset class and its performance through the most recent crisis
Radio Feature Three: Jean-Philippe Weisskopf in conversation with Sona Blessing
 
Wednesday, December 01, 2010
radio Jean-Philippe is a teaching and research assistant, Chaire de Gestion Financiere (Prof. Isakov), at the University of Fribourg, Switzerland where he is currently also a Ph.D. candidate in finance.
Together with his colleague Philippe Masset who is Professor in finance at the Ecole Hoteliere de Lausanne, they have authored a working paper in March earlier this year titled: "Raise your Glass: Wine Investment and the Financial Crisis." This paper uses auction hammer prices over the period 1996-2009, with a special emphasis on periods of economic downturn, to examine the risk, return and diversification benefits of investing in fine wine.

 Download this feature as MP3 (37.18 MB)

 
Listen to the complete feature
Wine as an asset class and its performance through the most recent crisis

Duration: 16:07 

 

Or listen to selected sub-features
  • Q1 - Share the salient findings of your research work.
    Their research shows evidence that the wine market is heterogeneous with wine regions and price categories evolving differently in terms of volume and turnover.

    Duration: 04:49 


  • Q2 - "Our findings confirm the cyclical nature of wine with returns primarily related to economic conditions and not to market risks."

    Duration: 00:49 


  • Q3 - In the context of wine investing - why he believes liquidity risk is the most important risk and the relevance of duration related risk

    Duration: 00:51 


  • Q4 - How should an investor know if they are over-paying for a wine.
    Whether it is "the right" wine to be investing in … and considerations in the context of investing En Primeur (wines futures).

    Duration: 1:34 


  • Q5 - Is there such a thing as “the right price” at which to buy a wine?

    Duration: 01:42 


  • Q6 - If the assumption is that wine prices are inflated; shouldn’t investors wait for a correction before allocating? Or do you believe irrespective, there will always continue to be opportunities?

    Duration: 01:35 


  • Q7 - When to invest vs. in which bottle of wine? To invest in a Bordeaux or not?

    Duration: 01:28 


  • Q8 - Has your data collection exercise, post March earlier this year, revealed the emergence of a recognisable trend?

    Duration: 01:43 


  • Q9 - Can, and under what circumstances will the upward trend in wine prices be sustained?

    Duration: 01:32 



Radio Link
  • Top Forwarded
  • Top Tracked
  • Top Searched
  1. Investing - Big hedge funds win again on PetSmart, Riverbed, RBS sells real estate loans to hedge fund Cerberus, Talisman energy speculation: Which hedge funds could benefit?[more]

    Big hedge funds win again on PetSmart, Riverbed From CNBC.com: Another week, another set of wins for activist investors. On Sunday, pet supply retailer PetSmart agreed to the largest leveraged buyout of the year at $8.7 billion. Hedge fund firm JANA Partners had been pushing for a sale a

  2. Outlook - Hedge fund manager who remembers 1998 rout says prepare for pain, Bond guru Bill Gross predicts U.S. economic growth to dip to 2%[more]

    Hedge fund manager who remembers 1998 rout says prepare for pain From Bloomberg.com: Stephen Jen landed in Hong Kong in early January 1997 as Morgan Stanley’s newly minted exchange-rate strategist for Asia. He was soon working around the clock when investors began targeting the region’s

  3. Investing - Hedge funds get boost from healthcare in 2014, Paulson & Co takes stake in Salix on heels of inventory issues[more]

    Hedge funds get boost from healthcare in 2014 From Valuewalk.com: The healthcare sector started the year on a turbulent note, as stocks of many major biotechnology companies were battered. However, most of the players in this sector have bounced back. The BarclayHedge Healthcare & Biotec

  4. North America - Why Steve Cohen, Connecticut hedge fund billionaire, gives so much in New York[more]

    From Insidephilantrophy.com: Billionaire Steve Cohen was born in Great Neck, New York before attending Wharton, working on Wall Street and then founding SAC Capital Advisors in Connecticut. Though his company (Point72) and foundation are based in Connecticut, Cohen and Alexandra are deeply connected

  5. Investing - Soros buys a highly speculative biotech in the third quarter[more]

    From Fool.com: …The Soros Fund bought 25,000 shares of the struggling small-cap biopharma Aegerion Pharmaceuticals in the third quarter. For those of you who haven't heard of this name, suffice to say that this was a surprising buy in light of the company's recent problems and poor outlook going for